Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia

Changed by Yuranga Weerakkody, 6 Oct 2014

Updates to Article Attributes

Body was changed:

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is an extremely rare pulmonary disorder where there is a proliferation of neuroendocrine cells within the lung. It is however recognised with increasing frequency.

Epidemiology

There may be an increased female predilection 3. Most patients tend to be non smokers.

Clinical presentation

Most are asymptomatic where discovery is made incidentally on thoracic imaging for an unrelated reason. Some however may present with symptoms such as an insidious cough or a slowly progressive dyspnoea 7.

Pathology

It is characterised by a generalised proliferation of scattered single cells, small nodules or linear proliferations of pulmonary neuroendocrine cells. It is sometimes considered to be a precursor for pulmonary carcinoid tumours.

Radiographic features

CT: HRCT chest

Various features have described each of which are non specific on their own. These include:

History and etymology

The first clinical series of six cases describing DIPNECH was published by Aguayo et al in 1992.

Treatment and prognosis

The rarity of the condition poses some clinical challenge on establishing treatment and assessing prognosis. Limited studies suggest that the condition can have a variable prognosis ranging from clinical improvement to being stable to clinical deterioration (rare 5). Various treatment strategies have been described which include systemic and inhaled corticosteroids, bronchodilators, and lung resection.

See also

  • -<li><a href="/articles/mucus-plugging">mucus plugging</a></li>
  • +<li><a title="Mucus plugging" href="/articles/mucoid-impaction">mucus plugging</a></li>
  • -</ul><h4>Treatment and prognosis</h4><p>The rarity of the condition poses some clinical challenge on establishing treatment and assessing prognosis. Limited studies suggest that the condition can have a variable prognosis ranging from clinical improvement to being stable to clinical deterioration (rare <sup>5</sup>). Various treatment strategies have been described which include systemic and inhaled corticosteroids, bronchodilators, and lung resection.</p><h4>See also</h4><ul>
  • +</ul><h4>History and etymology</h4><p>The first clinical series of six cases describing DIPNECH was published by <strong> Aguayo </strong> et al in 1992.</p><h4>Treatment and prognosis</h4><p>The rarity of the condition poses some clinical challenge on establishing treatment and assessing prognosis. Limited studies suggest that the condition can have a variable prognosis ranging from clinical improvement to being stable to clinical deterioration (rare <sup>5</sup>). Various treatment strategies have been described which include systemic and inhaled corticosteroids, bronchodilators, and lung resection.</p><h4>See also</h4><ul>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.